Free Ayush-64 drug for positive patients
Free Ayush-64 drug for positive patients
BySupriya DedgaonkarSupriya Dedgaonkar / Updated: May 13, 2021, 06:00 IST
Distribution of the kits will be done from today; ideal for those with mild to moderate symptoms
In order to help COVID-19 patients with mild and moderate symptoms, the availability of
Ayush-64, an ayurvedic medicine approved by the Centre, will be in place from Thursday onwards. Several citizens across the city with such symptoms can avail this free of cost.
The Union government has announced free distribution of Ayush-64 kits at
National Institute of Naturopathy in the city from Thursday. This particular announcement is made at a time when the nation is dealing with a massive surge in COVID-19 cases. The same will be available free of cost between 10 am and 5 pm.
Industry > Industry monitor > Healthcare
29 April 2021
Ayush 64, a poly-herbal preparation originally developed by the Central Council for Research in Ayurvedic Sciences (CCRAS) for the treatment of Malaria, in the year 1980 and now repurposed for the treatment Covid-19, has been found to be useful in the treatment of asymptomatic, mild and moderate Covid-19 infection as an adjunct to standard care.
Ministry of Ayush and the Council of Scientific and Industrial Research (CSIR) recently collaborated for robust multi-centre clinical trials to evaluate the safety and efficacy of Ayush 64 in the management of mild to moderate Covid-19 patients.
Clinical trials were conducted at KGMU, Lucknow; DMIMS, Wardha and BMC Covid Centre, Mumbai, involving 70 participants in each arm. Dr Chopra said Ayush 64 as an adjunct to standard of care (SoC) showed significant improvement and thus lesser period of hospitalisation compared to the only SoC procedure, Dr Arvind Chopra, director, Centre for Rheumatic Diseases, Pune and honorary chief clinical coordinator of the ministry of Ayush- CSIR collaboration, informed.
DCGI approves DRDO-developed anti-Covid oral drug, could reduce supplemental oxygen dependence
With no fixed therapeutic regimen to treat COVID-19, the stand on drugs recommended for the treatment of the SARS-CoV-2 infection has witnessed see-sawing since 2020. Now, the World Health Organization (WHO) has stated that it does not recommend the use of Ivermectin, a commonly prescribed and inexpensive anti-parasitic drug, for the treatment of the viral disease.
Dr. Soumya Swaminathan, Chief Scientist at WHO, tweeted on Tuesday, stating that the international health body recommended against the use of Ivermectin for treating COVID-19 patients (with the exception of clinical trials). The tweet comes at a time when several countries, and also many states in India, have approved the use of the drug for treating the respiratory illness.
Ayush Ministry launches distribution of AYUSH 64, Kabasura Kudineer
By IANS |
Published on
Fri, May 7 2021 19:36 IST |
4 Views
Ayush Ministry launches distribution of AYUSH 64, Kabasura Kudineer. Image Source: IANS News
New Delhi, May 7 : The Ministry of Ayush on Friday launched a massive nationwide campaign to distribute its poly herbal ayurvedic drugs AYUSH 64 and Kabasura Kudineer to the majority of out of hospital Covid patients.
In a statement the Ministry claimed that the efficacy of these drugs has been proved through robust multi-centre clinical trials. The multi stakeholder campaign being launched by the Minister of State (independent charge) for Youth Affairs and Sports and Minister of Ayush (additional charge) Kiren Rijiju will ensure that medicines reach the needy in a transparent and efficient manner. The main collaborator in the campaign is Sewa Bharati.
Ayush Ministry launches nationwide distribution campaign of herbal medicines
Multiple studies have been conducted on AYUSH-64, an Ayurvedic formulation developed by the Central Council for Research in Ayurvedic Sciences (CCRAS), and Kabasura Kudineer, a classical Siddha formulation
BusinessToday.In | May 7, 2021 | Updated 17:55 IST
The Ministry has stated that the efficacy of these drugs has been proven through robust multi-centre clinical trials
Ministry of Ayush on Friday announced that it is launching a massive nationwide campaign to distribute its polyherbal ayurvedic drugs AYUSH 64 and Sidha drug Kabasura Kudineer for the benefit of COVID-19 patients that have not been hospitalised. This announcement comes at a time when the nation is dealing with a massive surge in COVID-19 cases that has pushed the healthcare infrastructure of the country to its limit.
NEW DELHI: The Ayush ministry on Friday said it has launched a massive nationwide campaign to distribute its proven poly herbal ayurvedic drug AYUSH 64 and Sidha medicine Kabasura Kudineer for the benefit of Covid patients in home isolation.
The efficacy of these drugs has been proved through robust multi-centre clinical trials, the ministry said in its statement.
AYUSH-64 is recommended in National Clinical Management Protocol based on ayurveda and yoga which is vetted by National Task Force on Covid Management of ICMR and Guidelines for Ayurveda Practitioners for Covid-19 patients in home isolation.
Kabasura Kudineer is included in Guidelines for Siddha Practitioners for Covid 19 issued by the ministry of Ayush, the statement stated.
URL copied
How to build immunity? Ministry of AYUSH shares measures to protect against coronavirus
Health experts are advising everyone to adopt COVID-19 appropriate behavior to prevent the spread of coronavirus. Apart from this, emphasis is also being laid on maintaining strong immunity to prevent infection. The Ministry of AYUSH has shared some measures to protect from the Covid infection which help to increase immunity. These remedies are considered very effective in Ayurveda. Let's know about them.
The Ministry of AYUSH has advised everyone to drink hot water. Drink warm water several times throughout the day. Apart from this, gargle by adding a pinch of salt and turmeric in warm water.
All about AYUSH-64, polyherbal drug found useful in treating mild to moderate COVID cases
AYUSH-64 can be useful for the treatment of asymptomatic, mild and moderate COVID-19 infection cases, the Ministry of AYUSH said.
Share
Updated: May 3, 2021, 08:08 PM IST
AYUSH-64, a drug developed for curing malaria in 1980, can be useful for the treatment of asymptomatic, mild and moderate COVID-19 infection cases, the Ministry of AYUSH said on Thursday.
Central Council for Research in Ayurvedic Sciences (CCRAS) recently concluded clinical trials of the drug focusing on the management of asymptomatic, mild to moderate COVID-19 in collaboration with the Council of Scientific and Industrial Research (CSIR) and other research organizations and medical colleges across the country.